SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine Chem informs about disclosure

19 Apr 2025 Evaluate
NGL Fine Chem has informed that NGL Fine-Chem is not falling under the criteria of Large Corporate category as defined in the aforesaid circular. Further, the Company was not falling under the category of Large Corporate Entity for the FY 2024-25, there is no requirement as such to submit Annual Disclosure for Large Corporate Entities for the F Y 2024-25.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

2246.45 -82.85 (-3.56%)
13-Apr-2026 14:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1659.90
Dr. Reddys Lab 1231.20
Cipla 1212.00
Zydus Lifesciences 923.80
Lupin 2322.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×